Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Heise

Showing results (51-60 of 80) with videos related to

Pageof 8
Sort By:
Clinical Transplantation|September 17, 2011
Impact of stable PGI₂ analog iloprost on early graft viability after liver transplantation: a pilot studyErik Bärthel, Falk Rauchfuss, Heike Hoyer, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|August 22, 2006
Retrograde reperfusion via vena cava lowers the risk of initial nonfunction but increases the risk of ischemic-type biliary lesions in liver transplantation--a randomized clinical trialChristoph Heidenhain, Michael Heise, Sven Jonas, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|July 11, 2006
Response to transarterial chemoembolization as a biological selection criterion for liver transplantation in hepatocellular carcinomaGerd Otto, Sascha Herber, Michael Heise, et al.
Drug Design, Development and Therapy|July 27, 2017
Efficacy and safety of direct-acting antiviral therapy in previous hard-to-treat patients with recurrent hepatitis C virus infection after liver transplantation: a real-world cohortSebastian Bernuth, Daniel Grimm, Johanna Vollmar, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|January 24, 2012
Sorafenib for recurrence of hepatocellular carcinoma after liver transplantationArndt Weinmann, Ina Maria Niederle, Sandra Koch, et al.
Clinical Transplantation|November 1, 2013
Hepatocellular carcinoma in Child's A cirrhosis: a retrospective analysis of matched pairs following liver transplantation vs. liver resection according to the intention-to-treat principleDaniel Foltys, Tim Zimmermann, Moritz Kaths, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|July 30, 2011
The recipient CYP2D6 allele 4-associated poor metabolizer status correlates with an early fibrosis development after liver transplantationTim Zimmermann, Maria Hoppe-Lotichius, Andreas Körner, et al.
Transplantation Research|March 19, 2013
Protocol TOP-Study (tacrolimus organ perfusion): a prospective randomized multicenter trial to reduce ischemia reperfusion injury in transplantation of marginal liver grafts with an ex vivo tacrolimus perfusionSebastian Pratschke, Michael Eder, Michael Heise, et al.
Journal of Diabetes Science and Technology|September 2, 2011
A stepwise approach toward closed-loop blood glucose control for intensive care unit patients: results from a feasibility study in type 1 diabetic subjects using vascular microdialysis with infrared spectrometry and a model predictive control algorithmFranz Feichtner, Julia K Mader, Roland Schaller, et al.
Transplantation Direct|August 9, 2016
Results of the TOP Study: Prospectively Randomized Multicenter Trial of an Ex Vivo Tacrolimus Rinse Before Transplantation in EDC LiversSebastian Pratschke, Hannah Arnold, Alfred Zollner, et al.
Pageof 8

Showing results (51-60 of 80) with videos related to

Sort By:
Pageof 8
Clinical Transplantation|September 17, 2011
Impact of stable PGI₂ analog iloprost on early graft viability after liver transplantation: a pilot studyErik Bärthel, Falk Rauchfuss, Heike Hoyer, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|August 22, 2006
Retrograde reperfusion via vena cava lowers the risk of initial nonfunction but increases the risk of ischemic-type biliary lesions in liver transplantation--a randomized clinical trialChristoph Heidenhain, Michael Heise, Sven Jonas, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|July 11, 2006
Response to transarterial chemoembolization as a biological selection criterion for liver transplantation in hepatocellular carcinomaGerd Otto, Sascha Herber, Michael Heise, et al.
Drug Design, Development and Therapy|July 27, 2017
Efficacy and safety of direct-acting antiviral therapy in previous hard-to-treat patients with recurrent hepatitis C virus infection after liver transplantation: a real-world cohortSebastian Bernuth, Daniel Grimm, Johanna Vollmar, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|January 24, 2012
Sorafenib for recurrence of hepatocellular carcinoma after liver transplantationArndt Weinmann, Ina Maria Niederle, Sandra Koch, et al.
Clinical Transplantation|November 1, 2013
Hepatocellular carcinoma in Child's A cirrhosis: a retrospective analysis of matched pairs following liver transplantation vs. liver resection according to the intention-to-treat principleDaniel Foltys, Tim Zimmermann, Moritz Kaths, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|July 30, 2011
The recipient CYP2D6 allele 4-associated poor metabolizer status correlates with an early fibrosis development after liver transplantationTim Zimmermann, Maria Hoppe-Lotichius, Andreas Körner, et al.
Transplantation Research|March 19, 2013
Protocol TOP-Study (tacrolimus organ perfusion): a prospective randomized multicenter trial to reduce ischemia reperfusion injury in transplantation of marginal liver grafts with an ex vivo tacrolimus perfusionSebastian Pratschke, Michael Eder, Michael Heise, et al.
Journal of Diabetes Science and Technology|September 2, 2011
A stepwise approach toward closed-loop blood glucose control for intensive care unit patients: results from a feasibility study in type 1 diabetic subjects using vascular microdialysis with infrared spectrometry and a model predictive control algorithmFranz Feichtner, Julia K Mader, Roland Schaller, et al.
Transplantation Direct|August 9, 2016
Results of the TOP Study: Prospectively Randomized Multicenter Trial of an Ex Vivo Tacrolimus Rinse Before Transplantation in EDC LiversSebastian Pratschke, Hannah Arnold, Alfred Zollner, et al.
Pageof 8